Table 8 Medium-resolution HLA-A genotyping: status of common alleles by clinical activity status: all response-evaluable patients with medium-resolution HLA genotype data.
Allele* | Clinical Activity Status | n (%) | |||
|---|---|---|---|---|---|
| Â | Â | Allele Present | Allele Absent | Allele status unknown | Total |
02 | Benefit | 8 (72.7) | 3 (27.3) | 1 (8.3) | 12 (17.9) |
| Â | Non-Benefit | 28 (65.1) | 15 (34.9) | 3 (6.5) | 46 (68.7) |
| Â | Unknown | 3 (37.5) | 5 (62.5) | 1 (11.1) | 9 (13.4) |
24 | Benefit | 1 (10.0) | 9 (90.0) | 2 (16.7) | 12 (17.9) |
| Â | Non-Benefit | 12 (28.6) | 30 (71.4) | 4 (8.7) | 46 (68.7) |
| Â | Unknown | 2 (25.0) | 6 (75.0) | 1 (11.1) | 9 (13.4) |
03 | Benefit | 2 (20.0) | 8 (80.0) | 2 (16.7) | 12 (17.9) |
| Â | Non-Benefit | 9 (21.4) | 33 (78.6) | 4 (8.7) | 46 (68.7) |
| Â | Unknown | 2 (25.0) | 6 (75.0) | 1 (11.1) | 9 (13.4) |
01 | Benefit | 1 (16.7) | 5 (83.3) | 6 (50.0) | 12 (17.9) |
| Â | Non-Benefit | 8 (20.5) | 31 (79.5) | 7 (15.2) | 46 (68.7) |
| Â | Unknown | 2 (28.6) | 5 (71.4) | 2 (22.2) | 9 (13.4) |
11 | Benefit | 2 (20.0) | 8 (80.0) | 2 (16.7) | 12 (17.9) |
| Â | Non-Benefit | 6 (14.3) | 36 (85.7) | 4 (8.7) | 46 (68.7) |
| Â | Unknown | 1 (12.5) | 7 (87.5) | 1 (11.1) | 9 (13.4) |